NCT06659601View on ClinicalTrials.gov

Deep Learning Model to Predict the Recurrence of Stage IA Invasive Lung Adenocarcinoma After Sub-lobar Resection

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

January 1, 2024

Study Completion Date

October 24, 2024

Conditions
Focus on Developing a Deep Learning Model to Predict the Recurrence Risk of Stage IA Invasive Lung Adenocarcinoma After Sub-lobar Resection
Trial Locations (1)

400016

The First Affiliated Hospital of Chongqing Medical University, Yuzhong District

All Listed Sponsors
lead

First Affiliated Hospital of Chongqing Medical University

OTHER

NCT06659601 - Deep Learning Model to Predict the Recurrence of Stage IA Invasive Lung Adenocarcinoma After Sub-lobar Resection | Biotech Hunter | Biotech Hunter